Jim Simons Reviva Pharmaceuticals Holdings, Inc. Transaction History

Renaissance Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$4.42 - $8.55 $71,497 - $138,304	16,176 Added 84.58%	35,300 $207,000
Q1 2023 May 12, 2023	SELL	$3.79 - $4.87 $4,457 - $5,727	-1,176 Reduced 5.79%	19,124 $80,000
Q4 2022 Feb 13, 2023	BUY	$1.68 - $5.99 $34,104 - $121,597	20,300 New	20,300 $86,000
Q2 2022 Aug 12, 2022	BUY	$1.03 - $2.47 $5,665 - $13,585	5,500 Added 43.31%	18,200 $20,000
Q1 2022 May 13, 2022	BUY	$1.61 - $3.01 $20,447 - $38,227	12,700 New	12,700 $31,000
Q3 2021 Nov 12, 2021	SELL	$3.29 - $4.79 $37,012 - $53,887	-11,250 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$4.05 - $8.7 $45,562 - $97,874	11,250 New	11,250 $55,000

10M

133K

43.9K

Ticker RVPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,442,900
Market Cap $40.9M
Description
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.